Actinic Keratoses Treatment With Metvix® in Combination With Light

Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses

The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy in subjects with mild actinic keratoses (intra-individual comparison)

Inclusion Criteria:

• Male or female above 18 years;
• Subject with clinical diagnosis of mild Actinic Keratosis (AK) on the face or the scalp with or without clinical diagnosis of moderate AK on the target areas (TAs);

Exclusion Criteria:

• Subject with clinical diagnosis of at least one severe AK on TAs
• Subject with clinical diagnosis of other skin disease (including non-melanoma skin cancer) on the TAs;
• Subject with pigmented AK on the TAs